BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17093003)

  • 1. The in vitro drug interaction potential of dietary supplements containing multiple herbal components.
    Foti RS; Wahlstrom JL; Wienkers LC
    Drug Metab Dispos; 2007 Feb; 35(2):185-8. PubMed ID: 17093003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human P450 enzymes by natural extracts used in traditional medicine.
    Rodeiro I; Donato MT; Jimenez N; Garrido G; Molina-Torres J; Menendez R; Castell JV; Gómez-Lechón MJ
    Phytother Res; 2009 Feb; 23(2):279-82. PubMed ID: 18844254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS; Black SR; Patel PR; So J; Mathews JM
    Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of herb-drug metabolic interactions: a simulation study.
    Zhou S; Huang M; Xu A; Yang H; Duan W; Paxton JW
    Phytother Res; 2005 Jun; 19(6):464-71. PubMed ID: 16114078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acetylcholinesterase oxime-type reactivators K-48 and HI-6 on human liver microsomal cytochromes P450 in vitro.
    Veinlichova A; Jancova P; Siller M; Anzenbacher P; Kuca K; Jun D; Fusek J; Anzenbacherova E
    Chem Biol Interact; 2009 Aug; 180(3):449-53. PubMed ID: 19539805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary supplements on induction and inhibition of cytochrome P450s protein expression in rats.
    Jang EH; Park YC; Chung WG
    Food Chem Toxicol; 2004 Nov; 42(11):1749-56. PubMed ID: 15350672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
    Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
    Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro drug-drug interaction screens for canine veterinary medicines: evaluation of cytochrome P450 reversible inhibition.
    Aidasani D; Zaya MJ; Malpas PB; Locuson CW
    Drug Metab Dispos; 2008 Aug; 36(8):1512-8. PubMed ID: 18448570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract.
    Foti RS; Pearson JT; Rock DA; Wahlstrom JL; Wienkers LC
    Drug Metab Dispos; 2009 Sep; 37(9):1848-55. PubMed ID: 19541824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public safety and dietary supplementation.
    Gershwin ME; Borchers AT; Keen CL; Hendler S; Hagie F; Greenwood MR
    Ann N Y Acad Sci; 2010 Mar; 1190():104-17. PubMed ID: 20388141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of food and dietary supplements with drug metabolising cytochrome P450 enzymes.
    Nekvindová J; Anzenbacher P
    Ceska Slov Farm; 2007 Jul; 56(4):165-73. PubMed ID: 17969314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol.
    Hellum BH; Nilsen OG
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):350-8. PubMed ID: 17910620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of commercial preparations of herbal supplements commonly used by women on the biotransformation of fluorogenic substrates by human cytochromes P450.
    Ho SH; Singh M; Holloway AC; Crankshaw DJ
    Phytother Res; 2011 Jul; 25(7):983-9. PubMed ID: 21213356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential effects of herbal medicines and nutritional supplements on coagulation in ENT practice.
    Javed F; Golagani A; Sharp H
    J Laryngol Otol; 2008 Feb; 122(2):116-9. PubMed ID: 17640426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical evaluation of drug interactions with Echinacea spp.
    Freeman C; Spelman K
    Mol Nutr Food Res; 2008 Jul; 52(7):789-98. PubMed ID: 18618481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions in African herbal remedies.
    Cordier W; Steenkamp V
    Drug Metabol Drug Interact; 2011; 26(2):53-63. PubMed ID: 21756221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
    Bush TM; Rayburn KS; Holloway SW; Sanchez-Yamamoto DS; Allen BL; Lam T; So BK; Tran de H; Greyber ER; Kantor S; Roth LW
    Altern Ther Health Med; 2007; 13(2):30-5. PubMed ID: 17405676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions.
    Obach RS; Walsky RL; Venkatakrishnan K
    Drug Metab Dispos; 2007 Feb; 35(2):246-55. PubMed ID: 17093004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal medicine: potential for intoxication and interactions with conventional drugs.
    Poppenga RH
    Clin Tech Small Anim Pract; 2002 Feb; 17(1):6-18. PubMed ID: 11890130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
    Dasgupta A
    Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.